The Hepatoprotective Effect of Trigonelline in Diabetic Rat through Insulin-related IRS1- GLUT2 Pathway: A Biochemical, Molecular, Histopathological, and Immunohistochemical Study

ABSTRACT

Background: Diabetes significantly increases morbidity and mortality rates, causing complications such as cardiovascular disease, kidney failure, and blindness. Purpose: The aim of this study was to investigate the hepatoprotective effects of trigonelline (TRIG) in diabetic rats through the antioxidative, anti-inflammatory, and insulin-related IRS1-GLUT2 pathway. Materials and Methods: In this experimental investigation, sixty male Wistar rats (n = 10/group) were randomly divided into six groups: a healthy group (HEL), healthy rats treated with 1500 and 3000 mg/kg of TRIG, a diabetic (D), and diabetic rats treated with 1500 and 3000 mg/kg of TRIG (D+ TRIG). The effects of TRIG on rats with induced diabetes were evaluated by serum biochemical parameters, such as insulin, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), free fatty acids (FFA), nitric oxide, and adiponectin levels. The activities of hepatic carbohydrate metabolic enzymes (hepatic glucokinase, glucose 6-phosphatase, glycogen, and glucose-6-phosphate dehydrogenase) were also measured. Furthermore, the expression levels of genes and proteins associated with carbohydrate/lipid metabolism, including peroxisome proliferator-activated receptor gamma (PPARg), glucose transporter 2 (GLUT2), insulin receptor substrate 1 (IRS1), sterol regulatory element-binding protein 1c (SREBP-1c) were analyzed using real-time PCR and western blotting techniques, respectively. Liver sections were examined using H&E staining and immunohistochemistry targeting the p53 protein. Results: The results showed that 3000 mg/kg TRIG was able to suppress TNF-α, IL-6, and FFA by inhibiting inflammatory pathways along with increasing the activity of antioxidant enzymes. TRIG treatment regulated serum levels of insulin, adiponectin, and hepatic carbohydrate metabolic enzymes as well as glycogen content by regulation of the IRS1/ GLUT2- SREBP-1c/ PPARg pathway. Conclusion: These results provide evidence that TRIG has the potential to protect liver organs from oxidative damage in diabetic patients.

KEYWORDS

• Trigonelline
• liver
• alloxan
• diabetes
• insulin

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241247365Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 20, ISSUE 4Fraxinus excelsior L. for Prevention of Capecitabine-induced Enterocolitis in Rat: An Integrated Biochemical, Molecular, and Histopathological StudyLi Li, HaiYan Tan, TianLu Su · pp. 1086–1099Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Lijing-Anfei Decoction Attenuates COPD in a Mouse Model: Network Pharmacology Analysis, Molecular Docking, and Experimental ValidationJiajia Zhu, Jie Liu, Wei Jia, Guoqiang Shao, Haizhu Xu · pp. 1100–1113Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Anticancer Effects of Vaccinium arctostaphylos L. through HOTAIR/miR-124/Notch1 Axis of Hepatocellular Carcinoma in Rat: A Biochemical, Molecular, Immunohistochemical, and Histopathological ApproachesChengchen Zhou, Xiaoling Qin, Jingyi Wang, Yongchang Liu · pp. 1114–1127Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Eriocitrin in the Treatment of Diabetic Nephropathy: Amelioration Against Oxidative Burst and Inflammation ApproachHui Deng, Yarong Li, Shulan Han, Min Lan, Liqin Cui, Tahani Awad Alahmadi, Sulaiman Ali Alharbi, Zhong Li · pp. 1128–1140Original Research ArticleSame type: Article